Cyclo Therapeutics' Trappsol Phase 1/2 Trial In Niemann-Pick Type C1 Patients Meets Endpoints

Cyclo Therapeutics, Inc. (CYTH) Thursday announced that its phase 1/2clinical trial using intravenous trappsol in Niemann-Pick Type C1 patients met primary endpoints. The double blind study was done in patients aged 2 to 39 years in clinical sites in the U.K., Israel Sweden.

The company said the positive data might help advance its upcoming Phase 3 clinical trial in the coming quarter.

1500 mg/kg, 2000 mg/kg, and 2500 mg/kg and dose groups showed a favorable safety profile, consistent with previously reported data from a companion Phase 1 clinical trial.

Out of 9 patients, who completed the study, 8 met the first
efficacy endpoint.

The clinical stage biotechnology company noted that the genetic disease Niemann Pick C1 causes cholesterol accumulation in cells, leading to dysfunction of liver, lung, spleen and brain and premature death.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said it now intends to review only a small subset of new emergency use authorization or EUA requests for diagnostic tests. As per an updated COVID-19 test policy with a view to ensure continued access to tests, the regulator further urged developers of all test types seeking marketing authorization to pursue traditional premarket review for most test types. Netflix, Inc. said it is adding a new feature to offer a more personalized mobile games experience on the platform. In a statement, Sophia Yang, Product Manager, Mobile Games, said the company is rolling out the ability to create game handles, with which members will be able to create a unique public username. This can be used across all Netflix games. General Motors Co. has delayed its plan to require employees to return to office many days a week until next year, reports said citing an internal memo signed by CEO Mary Barra. Last week, the company had announced that corporate workers would be required to return to respective offices at least three days a week, beginning later this year, as the COVID-19 pandemic eases.
Follow RTT